The optimized nanomicelles could specifically target nucleolin-overexpressing cancer cells and elicit immunogenic cancer cell death, which further promoted antitumor immunity and synergistically enhanced the efficacy of anti-PD-1 immunotherapy in both 4T1 and H22 tumor-bearing mice.242. The gene discussed is NUCLEOLIN; the disease is cancer.